Oidtman, R.J.; Banniettis, N.; Weaver, J.; Matthews, I.R.; Ntais, D.; Meleleo, G.; Malik, T.M.; Lang, J.C.; Sharomi, O.
Predicting the Epidemiological Effects in the United Kingdom of Moving from PCV13 to PCV15 in the Routine Pediatric 1 + 1 Vaccination Schedule. Vaccines 2025, 13, 627.
https://doi.org/10.3390/vaccines13060627
AMA Style
Oidtman RJ, Banniettis N, Weaver J, Matthews IR, Ntais D, Meleleo G, Malik TM, Lang JC, Sharomi O.
Predicting the Epidemiological Effects in the United Kingdom of Moving from PCV13 to PCV15 in the Routine Pediatric 1 + 1 Vaccination Schedule. Vaccines. 2025; 13(6):627.
https://doi.org/10.3390/vaccines13060627
Chicago/Turabian Style
Oidtman, Rachel J., Natalie Banniettis, Jessica Weaver, Ian R. Matthews, Dionysios Ntais, Giulio Meleleo, Tufail M. Malik, John C. Lang, and Oluwaseun Sharomi.
2025. "Predicting the Epidemiological Effects in the United Kingdom of Moving from PCV13 to PCV15 in the Routine Pediatric 1 + 1 Vaccination Schedule" Vaccines 13, no. 6: 627.
https://doi.org/10.3390/vaccines13060627
APA Style
Oidtman, R. J., Banniettis, N., Weaver, J., Matthews, I. R., Ntais, D., Meleleo, G., Malik, T. M., Lang, J. C., & Sharomi, O.
(2025). Predicting the Epidemiological Effects in the United Kingdom of Moving from PCV13 to PCV15 in the Routine Pediatric 1 + 1 Vaccination Schedule. Vaccines, 13(6), 627.
https://doi.org/10.3390/vaccines13060627
